Close Menu

USPTO

The USPTO named Pac Bio the senior party in a patent interference with Life Technologies regarding single-molecule sequencing technology and methods.

Strands

Premium

Cenix BioScience, AstraZeneca, RXi Pharmaceuticals, Dicerna Pharmaceuticals, Intradigm, US Patent and Trademark Office, Integrated DNA Technologies, VH Bio, Asuragen, Agilent Technologies, Proceedings of the National Academy of Sciences

Tech Transfer Tidbits

Premium

Patent Reform Act reintroduced; FDA clears UF-developed wound care tech; GSK inks ophthalmology research pact with University College London, and more ...

On its website, the company informs customers that its service tests for the i4000377, i4000378, and i4000379 SNPs in BRCA1 and BRCA2 genes, either one of which may “influence your carrier status for breast/ovarian cancer.”

The patent, called “Fragment Complementation Assays for G Protein-Coupled Receptors and Their Signaling Pathways,” solidifies Odyssey’s position in complex-based assays, and adds depth to its IP coverage in these two areas, an Odyssey official told CBA News this week.

News Briefs

Premium

Cerenis, Montreal Heart Institute, UVA, Ortho Clinical, Mirna, UCSF, Case Western, Diagnostic Hybrids, iBridge Network, Ben Franklin Tech Partners, and more…

Pages

The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.

James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.

Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.

In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.